slides · global inventory
Present Solution
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 24,547
Current window 14,581-14,610
Pages 819
Rows per page 30
Slide function
14,581-14,610 of 24,547
10
ODR likely stands for Owner Direct Revenue or similar.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations Beat · Business Model1 hit
10
The slide uses a process-flow diagram to illustrate how different business segments contribute to long-term growth.Limoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
13
The slide uses a process flow diagram to map input sources to operating models, with a quantitative comparison of 2022 vs Target volume mix.Limoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
15
The slide highlights the financial benefits of an asset-light strategy, specifically citing per-carton margins and the elimination of capital expenditure for expansion.Limoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
16
The slide uses a bubble chart metaphor to show market share growth and a two-column table to list operational benefits.Limoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Solution & Approach1 hit
32
Limoneira | Investor Presentation Deck | 39 slidesLimoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Voice Of Customer1 hit
21
MainStreet Bancshares | Results Presentation Deck | 31 slidesMainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
22
The slide uses a 'not this, not that, but this' rhetorical structure to define their unique value proposition.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
03
Matinas BioPharma | Investor Presentation Deck | 31 slidesMatinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
04
The slide illustrates the self-assembly of Phosphatidylserine (PS) and Calcium ions into a cochleate structure.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
05
The slide uses a biological process diagram to illustrate how LNCs (Lipid Nanocochleates) leverage PS to enter cells.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
06
The slide uses a comparative structure to explain two distinct biological pathways for drug delivery.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
11
The diagram uses a hub-and-spoke model to define the 'ideal' product profile.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
12
Matinas BioPharma | Investor Presentation Deck | 31 slidesMatinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Solution1 hit
21
The slide uses a chevron-based timeline to illustrate the lifecycle management strategy.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
22
Includes MIC comparison, tissue fungal burden (lung/brain), and survival curves.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
28
The slide emphasizes long-term exclusivity through both patent filings and regulatory status (QIDP/ODD).Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
07
The slide uses a list of icons to represent key clinical attributes of the drug candidate.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
25
Nuvalent | Investor Presentation Deck | 31 slidesNuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
29
Nuvalent | Investor Presentation Deck | 31 slidesNuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
07
The slide uses a four-column layout to describe the biological composition of each product.Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations Beat · Solution1 hit
12
The charts are flow cytometry histograms showing CFSE dilution, a standard assay for cell proliferation.Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations 1 hit
23
Overstock | Results Presentation Deck | 34 slidesOverstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Visualization1 hit
14
The slide uses a biological process diagram to explain the drug's mechanism.PaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
Includes a medical illustration of the intranasal drug delivery pathway to the brain.PaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations Beat · Solution1 hit
08
The slide uses a combination of stacked bar charts for audience metrics and grouped bar charts for financial metrics to demonstrate the accretive nature of the acquisition.Playstudios | Mergers and Acquisitions Presentation Deck | 11 slides · Playstudios
Deck Investment bank 1 hit
04
The diagram shows the signaling pathway from extracellular receptor binding to nuclear cytokine induction.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
Includes a before-after comparison of medical efficacy and a market growth chart.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
13
Includes a biological pathway diagram illustrating the mechanism of action of PHAD on TLR4 pathways.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
15
Includes a small sketch of the test device with a 3-inch scale reference.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit